Incidence of Adverse Cardiac Events After Liver Transplantation in Patients With Different Hemodynamic Classifications of Pulmonary Hypertension
International Journal of Hepatology · 2026-01 · 2026 (1)
DOI: 10.1155/ijh/2869285 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hepatology, online erschienen am 27.06.2026. Verfasst von David W Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA, pitt.edu. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pulmonary hypertension (PH) in liver transplantation candidates is associated with elevated morbidity and mortality. Few studies have investigated whether different categories of PH based off hemodynamic characteristics portend worse outcomes. Furthermore, there have been newly defined parameters for PH classifications. Therefore, we aimed to compare postoperative outcomes after liver transplantation in patients within different newly established hemodynamic categories of PH.
Methods
This was a 20‐year single‐center retrospective observational study of adult patients undergoing liver transplantation. Patients with a diagnosis of PH and confirmatory right heart catheterization (RHC) were included in the study. Based off pulmonary artery wedge pressure (PAWP) and Wood units (WU), patients were categorized into four groups: precapillary (PrePH), isolated postcapillary (IpcPH), combined postcapillary (CpcPH), unclassified (UncPH). Our primary outcome was a composite of adverse cardiac events within 30 days postoperatively. Secondary outcomes included prolonged ventilation, acute kidney injury, and mortality at 30 days, 6 months, and 1 year.
Results
Of the 2409 patients who underwent liver transplantation in the study period, 80 patients met criteria for inclusion. The incidences of ACEs were 0% in PrePH, 31.4% in IpcPH, 25.0% in CpcPH, and 10.3% in UncPH ( p = 0.04). Patients with postoperative ACEs had elevated PAWP (18.1 vs. 14.0 mmHg, p = 0.01) and lower pulmonary vascular resistance (0.79 vs 1.3 WU, p = 0.01). There were no differences observed in secondary outcomes.
Conclusion
In this single‐center study, we observed that patients with isolated precapillary PH did not have adverse cardiac events. Instead, patients with elevated PAWP, indicating postcapillary PH, were more likely associated with adverse cardiac events. This observation is seen despite milder pulmonary disease, as intended by newly established definitions for PH. Further investigation is warranted, as there may be prognostic implications that can drive future guidelines for liver transplantation in patients with PH.
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA, pitt.edu.
ORCID-Profile: David W Wang, Akira Katayama, Marianne M Ligon, Samuel E Crowley, Abhijeet M Sathe, Ezeldeen Abuelkasem
Zitieren
APA
Wang, D. W., Katayama, A., Ligon, M. M., Crowley, S. E., Sathe, A. M., & Abuelkasem, E. (2026). Incidence of Adverse Cardiac Events After Liver Transplantation in Patients With Different Hemodynamic Classifications of Pulmonary Hypertension. International Journal of Hepatology, 2026(1). https://doi.org/10.1155/ijh/2869285
Vancouver
Wang DW, Katayama A, Ligon MM, Crowley SE, Sathe AM, Abuelkasem E. Incidence of Adverse Cardiac Events After Liver Transplantation in Patients With Different Hemodynamic Classifications of Pulmonary Hypertension. International Journal of Hepatology. 2026;2026(1). doi:10.1155/ijh/2869285
BibTeX
@article{Wang2026,
author = {Wang, David W and Katayama, Akira and Ligon, Marianne M and Crowley, Samuel E and Sathe, Abhijeet M and Abuelkasem, Ezeldeen},
title = {Incidence of Adverse Cardiac Events After Liver Transplantation in Patients With Different Hemodynamic Classifications of Pulmonary Hypertension},
journal = {International Journal of Hepatology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijh/2869285}
}
EUVIMED